1. Home
  2. Research Areas
  3. Cancer Research
  4. Various Products / Cancer Research

Various Products / Cancer Research

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
CAT# Product Name M.W Molecular Formula Inquiry
L01006 H-Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2 966.09
L01009 H-Leu-Gln-Val-Gln-Leu-Ser-Ile-Arg-OH 956.15
L01011 H-Tyr-Ile-Gly-Ser-Arg-NH2 593.68
L01012 H-Tyr-Ile-Gly-Ser-Arg-OH 594.7 C26H42N8O8
N05047 (Lys8-(R)-Lys9)-Neurotensin (8-13) 747 C38H66N8O7
N06013 Neuropeptide K, porcine C175H284N52O52S1
P03023 pTH (1-31) (human) 3719.35 C162H269N49O47S2
Q0301 (Hyp474.477,Gln479)-cyclo-α-Fetoprotein (471-479) (human, lowland gorilla) 986.07
S2302 SDF-1β (human) 8522.17
S2303 SDF-1α (human) 7959.43
T05062 H-Phe-Pro-Arg-OH 418.5 C₂₀H₃₀N₆O₄
T06028 Thrombospondin-1 (1016-1023) (human, bovine, mouse) 1128.4 C56H81N13O10S
T09029 Chlorotoxin (Cltx). 3996
T2804 Thymosin β10(human, rat) 4936.53
T3001 DABCYL-TNF-α-EDANS (-4 to +6) (human) 1573.8
T3002 Mca-(endo-1a-Dap(Dnp))-TNF-α (-5 to +6) amide (human) 1638.7 C69H103N23O24
V1326 VIP Antagonist 3467.11 C₁₅₄H₂₅₇N₄₉O₄₀S
X21205 Human PD-L1 inhibitor I 2350.5 C110H152N26O32
X21206 Human PD-L1 inhibitor II 2219.4 C103H151N25O30
X21207 Human PD-L1 inhibitor III 2223.7